Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Spinelli

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
JMIR Research Protocols|April 3, 2020
Testing a Real-Time Tenofovir Urine Adherence Assay for Monitoring and Providing Feedback to Preexposure Prophylaxis in Kenya (PUMA): Protocol for a Pilot Randomized Controlled TrialPaul Drain, Kenneth Ngure, Nelly Mugo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 22, 2026
Hair Testing to Detect Long-term Methamphetamine Use in People Living with and without HIVAyesha Appa, Marjan Javanbakht, Matthew Spinelli, et al.
AIDS (London, England)|October 28, 2022
Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimensGert van Zyl, Lauren Jennings, Tracy Kellermann, et al.
AIDS (London, England)|August 23, 2019
Racial/ethnic and HIV risk category disparities in preexposure prophylaxis discontinuation among patients in publicly funded primary care clinicsHyman M Scott, Matthew Spinelli, Eric Vittinghoff, et al.
AIDS Research and Human Retroviruses|November 15, 2021
Drug Resistance, Rather than Low Tenofovir Levels in Blood or Urine, Is Associated with Tenofovir, Emtricitabine, and Efavirenz Failure in Resource-Limited SettingsLauren Jennings, Tracy Kellermann, Matthew Spinelli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2022
Urine Tenofovir Levels Strongly Correlate With Virologic Suppression in Patients With Human Immunodeficiency Virus on Tenofovir Alafenamide-Based Antiretroviral TherapyKelly A Johnson, Hideaki Okochi, Mireya Arreguin, et al.
Eclinicalmedicine|March 26, 2019
Development and Validation of an Immunoassay for Tenofovir in Urine as a Real-Time Metric of Antiretroviral AdherenceMonica Gandhi, Peter Bacchetti, Warren C Rodrigues, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2026
Virologic Outcomes After LA ART Initiation with and without Viremia in Two Large U.S. Clinic CohortsMatthew Spinelli, Megan J Heise, David V Glidden, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 27, 2024
Identifying Implementation Determinants and Strategies for Long-Acting Injectable Cabotegravir-Rilpivirine in People With HIV Who Are Virally UnsuppressedMatthew D Hickey, Janet Grochowski, Francis Mayorga-Munoz, et al.
AIDS (London, England)|September 26, 2025
Suboptimal ART adherence, undetectable urine tenofovir, and higher C-reactive protein valuesDelaram Ghanooni, Megan J Heise, Kevin Sassaman, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
JMIR Research Protocols|April 3, 2020
Testing a Real-Time Tenofovir Urine Adherence Assay for Monitoring and Providing Feedback to Preexposure Prophylaxis in Kenya (PUMA): Protocol for a Pilot Randomized Controlled TrialPaul Drain, Kenneth Ngure, Nelly Mugo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 22, 2026
Hair Testing to Detect Long-term Methamphetamine Use in People Living with and without HIVAyesha Appa, Marjan Javanbakht, Matthew Spinelli, et al.
AIDS (London, England)|October 28, 2022
Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimensGert van Zyl, Lauren Jennings, Tracy Kellermann, et al.
AIDS (London, England)|August 23, 2019
Racial/ethnic and HIV risk category disparities in preexposure prophylaxis discontinuation among patients in publicly funded primary care clinicsHyman M Scott, Matthew Spinelli, Eric Vittinghoff, et al.
AIDS Research and Human Retroviruses|November 15, 2021
Drug Resistance, Rather than Low Tenofovir Levels in Blood or Urine, Is Associated with Tenofovir, Emtricitabine, and Efavirenz Failure in Resource-Limited SettingsLauren Jennings, Tracy Kellermann, Matthew Spinelli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2022
Urine Tenofovir Levels Strongly Correlate With Virologic Suppression in Patients With Human Immunodeficiency Virus on Tenofovir Alafenamide-Based Antiretroviral TherapyKelly A Johnson, Hideaki Okochi, Mireya Arreguin, et al.
Eclinicalmedicine|March 26, 2019
Development and Validation of an Immunoassay for Tenofovir in Urine as a Real-Time Metric of Antiretroviral AdherenceMonica Gandhi, Peter Bacchetti, Warren C Rodrigues, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2026
Virologic Outcomes After LA ART Initiation with and without Viremia in Two Large U.S. Clinic CohortsMatthew Spinelli, Megan J Heise, David V Glidden, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 27, 2024
Identifying Implementation Determinants and Strategies for Long-Acting Injectable Cabotegravir-Rilpivirine in People With HIV Who Are Virally UnsuppressedMatthew D Hickey, Janet Grochowski, Francis Mayorga-Munoz, et al.
AIDS (London, England)|September 26, 2025
Suboptimal ART adherence, undetectable urine tenofovir, and higher C-reactive protein valuesDelaram Ghanooni, Megan J Heise, Kevin Sassaman, et al.
Pageof 3